Canada issues final rules on classifying products as drugs, devices

03/18/2013 | Clinica (subscription required)

Health Canada has finalized guidelines for classifying therapeutic products as drugs or devices. The guidance sheds light on the considerations for determining whether a product is a medical device or drug, and it aims to promote a standardized and transparent process when deciding the appropriate regulatory pathway. The guidance notes that a product cannot be considered both a device and a drug.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA